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ABSTRACT
Respiratory syncytial viruses (RSVs) in ruminants are classified into two
subgroups, ovine RSV and bovine RSV. Although ovine RSV infects cattle, its
contribution to bovine respiratory tract disease has not been established which is an
important issue for vaccine development in cattle.
Diagnosis by virus isolation or serology has low or variable sensitivity and/or
specificity and PCR has been recommended as a rapid and sensitive technique for RSV
detection. Prior to this study, a laboratory test to differentiate between bovine and ovine
RSVs did not exist.
First, the nucleotide sequence of the ovine RSV fusion (F) gene was determined
and compared with representative strains of bovine RSV and human RSV subgroups A
and B. The ovine RSV F gene has 85% and 72-73% nucleotide identity with those of
bovine RSV and human RSV respectively. The predicted amino acid sequence of the
ovine RSV F gene has 94% and 83-84% amino acid identity with those of bovine RSV
and human RSV respectively.
Two RT-PCR assays have been developed for simultaneous detection of bovine
and ovine respiratory syncytial viruses. One, a set of primers amplified a 426 bp fragment
of either bovine or ovine RSV F gene (RT-PCR F). PCR-F products could be
distinguished by EcoRI or BstYI restriction endonuclease cleavage. In the other assay, a
set of primers amplified a 542 bp fragment of either ovine or bovine RSV G gene (RTPCR G). EcoO109I and RsaI restriction enzymes were used to differentiate between the
ovine and bovine PCR-G products. Sequencing of the PCR products confirmed the
fidelity of both assays.
iv

The two assays were evaluated using eight bovine RSV isolates, one ovine RSV,
one bighorn sheep RSV, one caprine RSV, two human RSV isolates and several viruses
associated with bovine respiratory tract disease.
The two PCR assays described in this study potentially constitute sensitive and
specific means for simultaneous detection of bovine and ovine RSV and differentiation
between them. However, RT-PCR F followed by the appropriate restriction enzyme
cleavage may be superior to RT-PCR G to discriminate between the two ruminant RSV
subgroups and for determining the relative contribution of ovine and bovine RSV to the
pathogenesis of bovine respiratory tract disease. This is relevant to the complete
understanding of RSV epidemiology and immunoprophylaxis.
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Part I
Literature Review
Respiratory Syncytial Virus Infections in Ruminants
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Abstract
Bovine respiratory syncytial virus (BRSV) has a worldwide distribution in the
cattle population and is associated with calf pneumonia in many countries. Ovine
respiratory syncytial virus (ORSV), caprine respiratory syncytial virus (CRSV) and
bighorn sheep RSV are isolates associated with respiratory tract diseases in sheep, goats
and Bighorn sheep respectively. Some studies indicated the possibility of interspecies
transmission of bovine and ovine RSVs. This review presents updated information on
respiratory syncytial viruses with an emphasis on those that affect ruminants.

History
Respiratory syncytial virus (RSV) was first isolated in 1956 from a laboratory
chimpanzee during an outbreak of illness resembling the common cold and was named
chimpanzee coryza agent (Morris et al., 1956). Shortly thereafter, it was isolated from
two children with respiratory tract disease in Baltimore, Maryland. Similar investigations
followed in many parts of the world that indicated RSV was associated with lower
respiratory tract disease in people (Beem et al., 1960; Chanock et al, 1961; Suto et al.,
1965; Tyrrell, 1965). The virus is designated respiratory syncytial virus which reflects the
characteristic effect of the virus on infected cells; the formation of large multinucleated
cells (syncytia) (Chanock and Finberg, 1957).
A similar virus to human respiratory syncytial virus (HRSV) had been suspected
to exist in cattle after detection of specific antibody in bovine serum that inhibited HRSV
growth in cell culture (Taylor-Robinson and Dogget, 1963; Dogget et al., 1968). Bovine
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respiratory syncytial virus (BRSV) then was isolated for the first time from conjunctivonasal specimens from two diseased animals in Switzerland (Paccaud and Jacquier, 1970).
At the same time, bovine RSV was isolated in 1970 from animals involved in an outbreak
of severe respiratory tract disease in Japan that included more than 40,000 cattle of all
ages (Inaba et al., 1970a; Inaba et al., 1970b; Inaba et al., 1972). Bovine RSV was first
isolated in US by two independent investigators in 1974 from cattle in Iowa and Missouri
(Rosenquist, 1974; Smith et al., 1974).
A sheep isolate of respiratory syncytial virus was characterized in 1983 (Everman
et al., 1985). A goat respiratory syncytial virus isolate was first reported in 1979 (Smith et
al., 1979). RSV was isolated from bighorn sheep in 1986 (Spraker et al., 1986).
In 1985, subgrouping of human respiratory syncytial viruses into two antigenic types (A
and B) was defined by reaction patterns with monoclonal antibodies (Anderson et al,
1985; Mufson et al., 1985).
Similarly, it has been proposed that ruminant RSVs be divided into 2 subgroups,
one representing bovine RSV and the other representing ovine RSV, based on analysis by
RNAse protection of the G glycoprotein transcripts and sequence comparison of ovine
and bovine RSV-G protein genes (Alansari and Potgieter, 1993; Alansari et al. 1999).

Viral properties
RSV virions grown in cell culture are heterogeneous in size and shape, consisting
of pleomorphic spherical particles that range from 80-350 nm in diameter and are up to
10 µm in length (Armstrong et al., 1962; Norrby et al., 1970; Bachi and Howe, 1973;
Bachi, 1988). RSV virion consists of a nucleocapsid contained within a lipid envelope.
3

The nuclocapsid contains the single strand of negative sense genomic viral RNA (Huang
and Wertz, 1982). Virions assemble at the plasma membrane of infected cells and mature
by budding, during which the intracellular nucleocapsid is packaged within a viral
envelope that is derived directly from the host cell plasma membrane (Norrby et al.,
1970; Bachi and How, 1973; Bachi, 1988). The envelope contains spike like projections
that are approximately 11-20 nm in length and are spaced at 6-10 nm interval (Norrby et
al., 1970; Bachi and How, 1973; Bachi, 1988).
RSV virions are extremely labile. However, infectivity can be stabilized by
sucrose or magnesium sulphate (Ueba, 1978; Fernie and Gerin, 1980). BRSV is sensitive
to low PH, ether, chloroform and is destroyed by heating at 56C for 30 minutes (Inaba et
al., 1970; Paccaud and Jacquier, 1970; Rosenquist, 1974). The infectivity titer of a BRSV
suspension decreases by about one log per 24 hours at 37C. The virus remains infectious
for at least 10 years when stored in liquid nitrogen (Wellemans, 1990).
The RSV genome (strain A2) is a single strand of negative sense RNA (Huang
and Wertz, 1982). Genomic RNA is neither capped nor polyadenylated (Mink et al.,
1991). Genomic RNA is tightly associated with N protein. The 3’ end of genomic RNA
consists of a 44-nucleotide extragenic leader region that is presumed to contain the major
viral promoter (Mink et al., 1991). The leader region is followed by the ten viral genes in
the order 3’ Ns1-Ns2-N-P-M-Sh-G-F-M2-L 5’ (Collins et al., 1986; Collins et al., 1987).
The last gene, L, is followed by a 155-nucleotide extragenic trailer region (Mink et al.,
1991). The first nine RSV genes are non-overlapping and are separated by intergenic
regions. The last two RSV genes, the M2 and L genes overlap (Collins et al., 1987).
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Three of the ten proteins are transmembrane surface proteins: the attachment
protein (G), the fusion protein (F) and the small hydrophobic protein (SH). Two proteins
are non-glycosylated virion matrix proteins (M and M2). Three proteins associated with
genomic RNA to form the viral nucleocapsid: the nucleoprotein (N), the phosphoprotein
(P) and the large catalytic subunit of the RNA polymerase (L). The two nonstructural
proteins (NS1 and NS2) accumulate in infected cells but are present in virions in trace
amounts (Collins et al., 1996).

Replication
Attachment and entry: The G protein mediates attachment of the virion to host
cells (Levine et al., 1987). The F protein mediates viral penetration into cells by fusion of
the viral envelope with the plasma membrane of the host cell. This has been directly
observed for RSV by video microscopy (Bachi, 1988). After penetration, the viral
envelope becomes incorporated into the cell surface (Routledge et al., 1987). The
nucleocapsid is released into the cytoplasm, and transcription is mediated by the viral
RNA polymerase. All events in the RSV replication cycle occur in the cytoplasm without
nuclear involvement (Kisch et al., 1962). Interaction between RSV proteins and cellular
receptors has been studied recently. RSV-G protein interacts with heparin and cellular
heparan sulfate (Krusat and Streckert, 1997). Also, RSV-F interacts independently with
heparin/ heparan sulfate suggesting that RSV-F protein can facilitate virus attachment
and infectivity in the absence of RSV-G protein (Feldman et al., 2000). Interaction of
RSV and ICAM-1 on human epithelial cells has been studied recently suggesting that

5

ICAM-1 facilitates RSV entry and infection of human epithelial cells by binding to F
protein (Behara et al., 2001).
Transcription and translation: RSV genes are transcribed in their 3’ to 5’ order
from a single promoter near the 3’ end of the genome (Dickens et al., 1990). The
polymerase contacts genomic RNA within the nucleocapsid in the leader region and
begins transcription. The polymerase completes transcription in a sequential stop-start
mechanism guided by the gene-start and the gene–end signals. The result is the synthesis
of a series of subgenomic mRNA which appear to be exact colinear copies of the genes,
with no evidence of mRNA editing, splicing, or other modifications (Collins et al., 1996).
The RSV mRNAs are capped at the 5’ end and polyadenylated at the 3’ end (Barik,
1993). A number of events occur at the gene junctions; polyadenylation and termination
of the completed mRNA, movement of the polymerase across the intergenic region, reinitiation at the next gene and capping and methylation of the nascent mRNA (Collins et
al., 1996). The intergenic regions do not contain important signals, and their length
difference does not seem to be important. Thus, the gene start and gene end signals
appear to be the only critical signals at the gene junction (Collins et al., 1996). The
relative abundance of each RSV mRNA decreases with the distance of its gene from the
promoter, presumably due to polymerase fall-off during sequential transcription (Dickens
et al., 1990). In addition to the ten unique mRNAs, a number of less abundant, larger
poly-transcripts are generated by transcriptional read–through of two or more adjacent
genes. This probably occurs because the polymerase sometimes fails to recognize a geneend signal and continues transcribing the next gene until it encounters the next gene-end
signal. These poly-transcipts likely are not essential gene products (Collins et al., 1996).
6

The L gene start signal lies 68 nucleotides upstream of M2 gene –end signal, resulting in
overlap (Collins et al., 1987). The presence of the M2 gene end-signal within the L gene
results in a high frequency of premature termination of L gene transcription (Collins et
al., 1996). Full length L mRNA is much less abundant, presumably full length is
generated when the polymerase fail to recognize the M2 gene-end motif (Collins et al.,
1996).
RNA replication: RNA replication is achieved by a switch from the stop-start
mode of mRNA synthesis to the anti-termination read-through mode (Collins et al.,
1996). This results in synthesis of positive sense replicative intermediate (RI) RNA that is
an exact complementary copy of genomic RNA. The latter then serves as a template for
synthesis of progeny genomes (Collins et al., 1996).
Virion morphogenesis: Progeny RSV virions mature by budding through areas
of the plasma membrane that contain localized accumulations of viral spikes (Armstrong
et al., 1962; Norrby et al., 1970; Bachi and How, 1973; Bachi, 1988).

Viral proteins
F protein: The fusion protein of paramyxoviruses is responsible for viral
penetration and syncytium formation of infected cells (Collins, 1991). RSV-F protein was
identified by immunoprecipitation with monoclonal antibodies that inhibits syncytium
formation in cell culture (Walsh and Hruska, 1983).
Experiments were done to determine whether F protein alone mediates fusion. It
was concluded that efficient fusion was obtained only with the co-expression of all three
surface proteins F, G, and SH (Heminway et al., 1993). The SH and G proteins might be
7

important for placing F in an optimal configuration with regard to the target membrane or
they might participate more directly in the conformational changes involved in fusion
(Collins et al., 1996). In a recent study, recombinant bovine RSVs lacking either the G
gene or SH gene and recombinants without both genes were generated. The deletion
mutants were fully competent for multicycle growth in cell culture suggesting that the SH
and G genes are not essential for replication (karger et al., 2001). Also, RSV-F protein
may interact independently with heparin/ heparan sulfate suggesting that RSV-F can
facilitate virus attachment and infectivity in the absence of RSV-G protein (Feldman et
al., 2000).
The RSV F protein is synthesized as a precursor F0, which is cleaved by a cellular
protease to generate two disulphide–linked subunits, NH2-F2-F1-COOH (Walsh et al.,
1985). The BRSV F mRNA consists of 1899 nucleotides and has a single major open
reading frame which codes for a polypeptide of 574 amino acids with a molecular weight
of 63.8 KDa (Lerch et al., 1991). Residues 1-26 of this polypeptide represent NH2
terminal signal sequence and residues 131-136 represent a site for proteolytic cleavage to
generate the disulphide-linked F1 and F2 subunits. Residues 522-549 represent the
hydrophobic trnsmembrane anchor sequence (Lerch et al., 1991).
The ovine RSV F gene has 85% and 72-73% nucleotide identity with those of
bovine RSV and human RSV respectively (Eleraky et al., 2001). The predicted amino
acid sequence of the ovine RSV F gene has 94% and 83-84% amino acid identity with
those of bovine RSV and human RSV respectively (Eleraky et al., 2001). Bovine and
ovine RSV F genes have nearly the same level of nucleotide and amino acid identity with
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human RSV F gene (Walravens et al., 1990; Lerch et al., 1991; Himes and Gershwin,
1992; Eleraky et al., 2001).
The molecular weights of the F2 fragments in HRSV (long strain) and some
BRSV isolates (A51908 and Mdx) were approximately 20 KDa whereas those of CRSV
and other BRSV isolates (FS-1, VC-464) were 15.5 KDa. The molecular weight of the F1
was 48 KDa in all isolates examined (Mallipidi and Samal, 1993 b). This variation in the
size of F2 polypeptides may be due to the differences in the extent of glycosylation
(Mallipidi and Samal, 1993 b).
The fusion protein is superior to the attachment protein G in inducing neutralizing
antibodies (Olmsted et al., 1986; Westenbrink et al., 1989) and for eliciting cytotoxic T
cells (Pemberton et al., 1987; Cannon and Bangham, 1989). Most neutralizing antibodies
have been mapped to the fusion glycoprotein F (Arbiza et al.; 1992, Lopez et al., 1990;
Lounsbach et al. 1993; Paradiso et al., 1991;Scopes et al., 1990; Taylor et al., 1992;
Walsh et al., 1986; and West et al., 1994). Many experimental studies suggest that the
RSV fusion protein is the major protective antigen (Wertz et al., 1987; Stott et al., 1987;
Olmsted et al., 1986 and Olmsted et al., 1988). Two neutralizing fusion-inhibiting bovine
monoclonal antibodies directed at different epitopes on the fusion protein of RSV
protected the lungs of gnotobiotic calves from RSV infections (Thomas et al., 1998). A
conserved neutralization site (173 STNKAVVSLS 182) has been identified in BRSV and
HRSV F proteins (Langediijk et al., 1998). This site is located on the N-terminus of F1,
adjacent to the hydrophobic, putative fusion related region (Langediijk et al., 1998). This
site is also conserved in Ovine RSV fusion protein (Eleraky et al., 2001). It has been
proposed that this linear conserved epitope may be a potential candidate for a peptide9

based vaccine, which can induce neutralizing antibodies against all RSV groups and
subgroups (Langediijk et al., 1998).
Ruminant RSV have been grouped into two subgroups based on the reactivity of
three monoclonal antibodies specific to BRSV-F protein (Pastey and Samal, 1997)
supporting the existence of antigenic variation among ruminant RSVs (Pastey and Samal,
1997). The F protein of BRSV was expressed in a baculovirus vector (Himes and
Gershwin, 1992; Pastey and Samal, 1998) and was proposed as an antigen for detecting
antibodies to BRSV in enzyme immunoassay (Pastey and Samal, 1998).
G protein: Antibodies specific to RSV-G protein inhibited the adsorption of
virions to the cells, whereas antibodies to the F protein inhibited syncytium formation but
not virus adsorption (Levine et al., 1987). Therefore, G protein is the viral attachment
protein. G protein lacks hemagglutination and neuraminidase activity (Richman et al.,
1971).
G protein is the most divergent viral protein among RSV strains (Lerch et al.,
1990; Alansari and Potgieter, 1993). A 53% amino acid identity between the G protein of
subgroups A and B of HRSV exists (Johnson et al., 1987) and is similar to that between
the G protein of ORSV and BRSV [62%] (Alansari and Potgieter, 1993). BRSV G
protein has 29-30% amino acid identity with that of HRSV (Lerch et al., 1990). ORSV G
protein has 21-29% amino acid identity with that of HRSV. G proteins of ORSV and
BRSV differ substantially from that of HRSV. Analysis of the G glycoproteins clearly
segregates ruminant RSV isolates from human RSV isolates and the relationship between
A and B subgroups of HRSV is analogous to that between BRSV and ORSV isolates
(Alansari and Potgieter, 1993).
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The central hydrophobic region of the ectodomain encompassing amino acids
166-186 may be a putative receptor binding site in the HRSV G protein (Johnson et al.,
1987). This region is not conserved in the ORSV or BRSV G protein and only six out of
the 13 amino acids in this region were conserved among all RSV strains (Mallipedi and
Samal, 1993).
SH protein (Small hydrophobic region ): SH protein contains a central core of
hydrophobic amino acids flanked by short N-terminal and C-terminal domains that each
contains a potential acceptor site for N-linked carbohydrate (Collins and Wertz, 1985).
The function of the SH protein is unknown, but its status as an integral membrane protein
suggests that it might be involved in attachment, penetration, uncoating and/or virion
morphogenesis (Collins et al., 1996). SH protein greatly enhances membrane fusion when
it is co-expressed with the F and G protein (Heminway et al., 1994). The SH gene and its
encoded protein differ significantly among human, bovine, and ovine RSV isolates
(Anderson et al., 1992; Collins et al., 1990; Samal and Zamora, 1991; Alansari and
Potgieter, 1994a).
Nucleocapsid-associated protein N, P, and L: RSV has three nucleocapsidassociated proteins N, P, and L. N protein is the RNA binding major nucleocapsid
protein, P protein is a phosphoprotein, and L protein is a large polymerase subunit
(Collins et al., 1996). RSV L protein is similar in size to its rhabdovirus and
paramyxovirus counterparts and contains six conserved segments, which presumably
represent functional domains (Stec et al., 1991). Comparison of amino acid sequences of
L protein of BRSV with those of HRSV A2 and avian pneumovirus revealed 84% and
64% identity respectively (Yunus et al., 1999). Comparison of RSV-N protein with the
11

N-terminal 400 amino acids of the N proteins of various non-segmented, negative strand
viruses revealed that all contain three segments of similar sequence and predicted
secondary structure (Barr et al., 1991). N protein is the most conserved protein between
HRSV and ruminant RSV isolates (Alansari and Potgieter, 1994b). ORSV P protein has
90% and 81% identity with those of BRSV and HRSV respectively (Alansari and
Potgieter, 1994b).
Matrix proteins (M and M2): Pneumoviruses differ from other non-segmented,
negative strand RNA viruses with respect to their matrix proteins. The former have two
matrix proteins M and M2, whereas the latter have only one (Huang et al., 1985).
Pneumovirus M protein corresponds to the M protein of other paramyxoviruses, but M2
may not have a counterpart in other paramyxoviruses (Collins et al., 1996). The M
protein of non-segmented, negative-strand viruses likely have two general functions;
rendering the nucleocapsid transcriptionality inactive before packaging and mediating
association of the nucleocapsid with the nascent envelope (Collins et al., 1996). In
pneumoviruses, these functions of the M protein may be shared between the M and M2
proteins (Collins et al., 1996). The ORSV M protein has 97% and 90% amino acid
identity with those of BRSV and HRSV respectively (Alansari and Potgieter, 1994b). The
level of amino acid identity between M2 of ORSV and those of BRSV and HRSV was
93% and 82% respectively (Alansari and Potgieter, 1994b). The M and N proteins may
be the most conserved protein among ruminant RSV isolates (Alansari and Potgieter,
1994b).
Nonstructural proteins NS1 and NS2: The functions of NS1 and NS2 proteins
are unknown. They may have roles in regulating RNA synthesis or in virion
12

morphogenesis (Collins et al., 1996). A NS2-deficient BRSV replicated autonomously
and could be passaged demonstrating that NS2 is not essential for virus replication in cell
culture. However, growth of the mutant was considerably slower than that of the wild
type and the final infectious titer was reduced indicating that NS2 provides a supporting
factor required for full replication capacity (Buchholz et al., 1999). Recent work
suggested that bovine respiratory syncytial virus nonstructural proteins NS1 and NS2
have the potential to cooperatively antagonize alpha/beta interferon-induced antiviral
response (Schlender et al., 2000). The amino acid sequence of BRSV NS1 and NS2 have
been compared to those of ORSV and HRSV A and B. The amino acid identity between
BRSV and ORSV is higher than that between BRSV and HRSV (Pastey and Samal,
1995). That supports also segregation of ruminant RSV isolates from human isolates.

Classification
RSVs belong to the family Paramyxoviridae, subfamily Pneumovirinae, genus
Pneumovirus (Collins et al., 1996). The pneumoviruses are classified as a separate genus
because the nucleocapsid diameter is narrower (12-15nm) than that of paramyxoviruses
(18nm) and because of the lack of detectable viral hemagglutination activity for RSV
(Kingsbury et al , 1978; Richman et al 1971). The pneumoviruses, like the
morbilliviruses, lack a neuraminidase (Collins et al., 1996). Respiratory syncytial viruses
are enveloped, single stranded, nonsegmeneted, negative-sense RNA viruses. The
pneumoviruses encode a larger number of mRNAs (ten) than paramyxoviruses (six or
seven) although the length of the genomic RNA are similar (Collins et al., 1996). The
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genes NS1, NS2, SH and M2 of pneumoviruses have no counterparts in most of the
paramyxoviruses (Collins et al., 1996).
RSV subgrouping: Two antigenic subgroups, A and B, were defined for HRSV
on the basis of reaction patterns with monoclonal antibodies (Mufson et al., 1985;
Anderson et al., 1985; Gimenez et al., 1986, Hendry et al., 1986). Antigenic diversity of
HRSV is associated with extensive degree of amino acid sequence divergence (53%)
between the G protein of the two subgroups (Johnson et al., 1987).
The attachment glycoprotein G of BRSV differs antigenically from that of HRSV,
whereas the bovine RSV F, N, M, and P proteins cross-react with those of human RSV
(Lerch et al., 1989). Heterogeneity among 19 BRSV strains has been studied by using
monoclonal antibodies specific for the G protein. Although two antigenic subgroups were
identified (Furze et al., 1994), sequence data revealed a high degree of amino acid
identity (85%) among the strains of suggested subgroups of BRSV (Furze et al., 1997;
Prozzi et al., 1997). These findings are in sharp contrast to HRSV subgrouping, where
only 53% identity between members of A and B subgroups exists (Johnson et al., 1987).
Therefore, BRSV isolates may constitute a continuum of slightly different strains within
a single subgroup rather than distinct subgroups (Prozzi et al., 1997, Stine et al., 1997).
Subsequent work resulted in a proposal that ruminant RSVs be divided into 2
subgroups, one representing bovine RSV and caprine RSV, and the other representing
ovine RSV. This was based on analysis by RNAse protection of the G glycoprotein
transcripts using two (bovine and ovine) antisense radiolabelled RNA probes (Alansari et
al., 1999). Moreover, the ovine and bovine RSV G glycoprotein genes have nucleotide
identity (70%) and amino acid identity (62%) nearly similar to those that exist between
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the two human RSV subgroups (67% and 53% respectively). (Alansari and Potgieter,
1993). This supported the ruminant RSV isolates subgrouping hypothesis. Some other
studies on the F protein of bovine and ovine RSV have supported this hypothesis. In one
study, antigenic variation between bovine and ovine RSV with monoclonal antibodies to
the F protein of bovine RSV was reported (Pastey and Samal, 1997). In another study, the
level of identity between ovine and bovine RSV F genes (85%) and their predicted
proteins (94%) are close to those found between the two human subgroups A and B, 80%
nucleotide identity and 90% amino acid identity (Eleraky et al., 2001).

Clinical disease
Human: HRSV infection is a major cause of respiratory tract disease in infants
and young children. The disease is characterized by pneumonia and bronchiolitis (Avila
et al., 1989; Tsutsumi et al., 1991). In older children and adults, HRSV causes moderate
to severe upper respiratory tract symptoms (Finger et al., 1987; Agius et al., 1990).
Cattle: BRSV is considered to be one of the most important causes of respiratory
tract disease in cattle (Inaba et al., 1972; Stott et al., 1980; Verhoeff et al., 1984; Baker et
al., 1997; Caldow et al., 1993). Severe respiratory disease has been reported in calves less
than 6 months of age (Bryson et al., 1978; Pirie et al., 1981; Kimman et al., 1988;
Vanderpoel et al., 1993). Severe respiratory disease affecting adult cattle has been
recorded also (Harrison et al., 1985; Castlman et al., 1985; Elvander et al., 1996; Ellis et
al., 1996). The symptoms include cough, nasal discharge, conjunctivitis and lacrimation.
The disease is associated with pyrexia and in some cases signs of lung emphysema may
occur after 2-3 days. Some animals may have difficulty in breathing that may be
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accompanied by dry cough with rapid and shallow breathing. Abdominal respiration
sometimes develops (Wellemans, 1990).
Sheep and goats: Ovine RSV was isolated from a one-year-old ewe with rhinitis
(Evermann et al., 1985). Experimental infection of three month-old lambs with ORSV
induced mild conjunctivitis. Clinical signs of pneumonia were not observed, but gross
and microscopic evidence of pulmonary inflammation did develop. Lung lesions were
more severe when ORSV infection was accompanied with Mannheimia hemolytica
(Evermann et al., 1985). Signs of clinical illness, pulmonary lesions, and seroconversion
occurred in lambs experimentally inoculated with a BRSV isolate (Lehmkuhl and Cutlip
1979; Sharma and Woldehiwet, 1991). RSV infection is widespread in free-ranging
Bighorn sheep populations and RSV may be an important factor in the Bighorn sheep
pneumonia-complex (Dunbar et al., 1985). RSV was isolated from Bighorn sheep with
respiratory symptoms (Spraker et al.,1986; Evermann et al., 1994). Caprine RSV was
isolated from a herd of pygmy goats with respiratory disease (Smith et al., 1979). Natural
infection with BRSV has been recorded in eight cases in a herd of 50 Murciana kids from
an intensive goat farm in Spain. In two of the eight cases, concurrent infection with
Mannheimia hemolyica A occurred (Redendo et al., 1994).

Pathogenesis and epidemiology:
The means of transmission of BRSV is mostly by contact with respiratory
secretions from infected cattle and by the aerosol route (Baker et al., 1997). Once a herd
in a region is affected, the disease rapidly spreads from farm to farm (Wellemans, 1990).
Mortality may reach 20% (Wellemans, 1990). Outbreaks of respiratory disease associated
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with BRSV peak in autumn and winter (Baker et al., 1985; Van der Poel et al., 1993), but
some epidemics have occurred in spring and summer (Wellemans, 1990). BRSV
infection occurs in both dairy and beef cattle (Baker et al., 1997). Infections resulting in
severe clinical disease are mostly observed in calves under 6 months of age (Bryson et al.
1978; Kimman et al. 1988, Pirie et al 1981; Van der Poel et al. 1993). Severe signs of
respiratory tract infections also have been observed in adult cattle (Castleman et al.,
1985; Harrison et al. 1985; Elvander, 1996; Ellis et al. 1996). Severe clinical signs in
adult cattle likely relate to a primary exposure to the virus (Baker et al., 1997). The
factors responsible for severity of the disease are unknown, but concurrent viral, bacterial
and mycoplasmal infections, housing and management conditions, weather conditions
and passively acquired antibody titer may have roles in outcome of the disease (Van der
poel et al., 1994).
Maternal antibodies can be detected in calves for up to about three months (Baker
et al., 1986 a). Although maternally derived antibodies do not effectively prevent the
disease, they may reduce severity of the disease in colostrum-fed calves (Belknap et al.,
1991). Mucosal and systemic IgA responses are inhibited in calves when maternally
derived antibodies are present at the time of infection (Kimman et al., 1987). Humans of
all ages are regularly reinfected with human RSV (Glizen et al., 1986). Similarly, cattle
are regularly reinfected by bovine RSV (Van der Poel et al., 1993).
The existence of persistent infections of BRSV have been suspected because of
re-occurrence of BRSV in closed populations (Van der Poel et al., 1993). This led to a
hypothesis that BRSV may persist in some cows during summer and serve as a source of
new outbreaks in autumn or winter (Van der Poel et al., 1993). Experimental studies to
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support this hypothesis revealed serological evidence of persistence of BRSV in cattle but
the virus or its RNA has not been detected in these populations (Van der Poel et al.,
1997).
Immunologic response has been implicated in the pathogenesis of BRSV
infection. Disease severity correlated with production of BRSV-specific IgE in
experimentally infected calves suggesting that type I hypersensitivity response can have a
role in BRSV infection (Stewart and Gershwin, 1989a, b).
The role of non-bovine species in the epidemiology of BRSV infections has been
investigated. Sera from cattle, nine non-bovine species and people that had contact with
cattle were examined for BRSV-specific antibodies in a BRSV G-peptide ELISA. BRSVspecific antibodies have been found in all cattle tested, goats (27.5%) and occasionally in
some other animals (horses, roe, cat, and dog). That study suggested that beside cattle,
only goats may have a role in the epidemiology of BRSV (Van der Poel et al., 1995). A
serological survey of pigs in Northern Ireland using BRSV antigens revealed 41%
positive rate by immunofluorescence (Allan et al., 1998). In that study, the
immunofluorescent-staining pattern observed with the majority (63%) of BRSV-reactive
pig sera was similar to that observed with known BRSV-reactive bovine sera. The other
immunoreactive pig sera stained BRSV infected cell culture in an atypical pattern
suggesting that more than one serotype of a porcine pneumovirus may exist (Allan et al.,
1998). Antibodies to BRSV have been found in sheep (Berhiaume et al., 1973; Adair et
al., 1984). Experimental infection of lambs with BRSV produced mild clinical signs and
some pulmonary lesions (Lehmkuhl and Cutlip, 1979; Sharma and Woldehiwet, 1991).
Existance of two related but antigenically distinguishable RSV types in sheep has been
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suggested, one of them is similar to bovine strains (Adair and McFerran, 1987).
Inoculation of ORSV into calves and deer fawns resulted in mild to moderate clinical
respiratory disease in calves but not in fawns. Lesions were detected and ORSV was reisolated from the lower respiratory tract of calves and fawns (Bryson et al., 1988).
Subgroup-specific peptide-based ELISA, derived from the unique central
hydrophobic region of the ovine and bovine G-glycoprotein respectively, has been used
to determine the prevalence of antibodies against ovine and bovine subgroup strains of
RSV in cattle. The prevalence was 56-60% for the bovine strains and 15.9% for the ovine
strain (Grubbs et al., 2001 a; Grubbs et al., 2001 b). Recently, PCR assay targeting F gene
has been recommended to detect both bovine and ovine RSV and simultaneously
differentiate between them (Eleraky et al. 2001). This assay may be useful to understand
the epidemiology of RSV in ruminants.

Pathology
Lesions that have been associated with BRSV natural and experimental infection
include lung consolidation, interstitial pneumonia, lung edema and emphysema.
Microscopically, interstitial pneumonia, interstitial edema, necrotic bronchiolitis and
multinucleated syncytial epithelial cells on bronchial and alveolar walls have been
reported (Bryson et al., 1983; Castlemann et al., 1985; Kimman et al., 1989; Appel and
Heckert, 1989).
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Immune response
Several experimental studies suggested that the RSV fusion protein F is the major
protective antigen (Wertz et al., 1987; Stott et al., 1987; Olmsted et al., 1986; Olmsted et
al., 1988). However, the G protein also has a role in eliciting a protective immunity
(Taylor et al., 1997; Plotnicky- Gilquin et al., 2000).
Although maternally derived antibodies do not effectively prevent disease, they
may reduce severity of disease in colostrum-fed calves (Belknap et al., 1991). Mucosal
and systemic Ig A responses are inhibited in experimentally infected calves when
maternally derived antibodies are present at the time of infection (Kimman et al., 1987).
Specific neutralizing antibody responses and positive lymphocyte proliferative
responses were detected in calves experimentally infected with BRSV (knott et al., 1998).
Data from a recent study suggests that most BRSV experimentally infected calves
experience an increase in specific IgM and IgG1 titers about 6-10 days after infection
with BRSV (Uttenthal et al., 2000). The IgM titer was transient, lasting for only 5-10
days. IgA was detected concomitantly with IgM but at a lower level. Production of IgG2
anti-BRSV antibodies was detected three weeks after infection (Uttenthal et al., 2000).
CD8+ T lymphocytes may have a central role in the recovery of calves from RSV
infection (Taylor et al., 1995, Gaddum et al., 1996; Thomas et al., 1996). The
demonstration of CD8+ CTL in the lungs at a time when bovine RSV was being cleared
implicated the importance of these cells in recovery from infection (Gaddum et al., 1996).
The depletion of CD8+ T-lymphocytes with a CD8-specific monoclonal antibody was
associated with an enhanced pneumonic consolidation in calves experimentally infected
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with BRSV. However, calves depleted of the CD4+ subpopulation also had enhanced
macroscopic lesions but with less active histological lesions (Thomas et al., 1996).
In one study, BRSV significantly suppressed lymphocytes response to
phytohemagglutinin in experimentally infected lambs (Sharma and Woldehiwet, 1991).

Immunization
In contrast to modified-live virus vaccines, inactivated vaccines stimulate low
concentration of virus neutralizing antibodies and high concentration of non-neutralizing
antibodies (Ellis et al., 1995). Certain inactivation processes may alter functionally
important epitopes on BRSV envelope glycoproteins, leading to production of
predominantly non-neutralizing antibodies in immunized cattle (Ellis et al., 1995). In the
late 1960s, a formalin-inactivated vaccine not only failed to protect vaccinated children
against RSV but also sensitized vaccinated children who suffered more serious disease
after infection than unvaccinated children (Kim et al., 1969). However, vaccinal serum
antibodies elicited by inactivated vaccine was not associated with disease enhancement
following experimental infection in calves with BRSV (Mohanty et al., 1981). In another
study, an inactivated BRSV vaccine elicited clinical protection against subsequent
experimental infection with virulent virus and decreased the severity of pulmonary
lesions in vaccinated animals (Ellis et al., 2001). Efficacy was similar to that of modified
live virus vaccine (Ellis et al., 2001).
BRSV vaccines can be administered to pregnant cattle during late gestation to
induce a high level of BRSV specific antibodies in colostrum (Ellis et al., 1996 a).
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Several modified live virus BRSV vaccines are available and most contain BRSV
in combination with other viral and bacterial pathogens (Baker et al., 1997). Vaccination
with BRSV modified virus vaccines significantly reduced the clinical disease and
pulmonary pathology in calves (Verhoeff et al., 1984; West et al., 1999). In vitro assays
of cellular immunity more consistently correlated with vaccine-induced protection than
presence of post-vaccination serum antibody (West et al., 1999).
A peptide representing amino acids 174-187 of BRSV G glycoprotein has been
used to induce protection in mice against BRSV challenge (Bastein et al., 1999).
Immunization with a recombinant F protein, expressed in insect cells, with Quail
A adjuvant induced neutralizing antibodies and protection in mice against BRSV
challenge (Walravens et al., 1996). Recombinant vaccinia viruses expressing the F, G or
N protein of BRSV induced resistance to BRSV challenge in calves (Taylor et al., 1997).
A bovine Herpesvirus 1 (BHV1) vector vaccine carrying a gene encoding the BRSV G
protein induced protection in calves against BRSV and BHV1 infections (Schrijver et al.,
1997). Significant protection against RSV infection was induced in mice vaccinated with
DNA encoding the F or G protein of RSV (Bembridge et al., 2000). Immunization using
plasmid DNA encoding the RSV G glycoprotein induced protective effects in mice and
cotton rats (Li et al., 2000).

Diagnosis
Virus isolation: BRSV is labile outside the host and is thought to lose viability
during transport to a laboratory. BRSV is thermolabile and is sensitive to freeze- thawing
(Baker, 1992). Successful isolation of BRSV in cell culture may require multiple
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subpassages (Baker, 1992). BRSV isolation is not recommended as a routine procedure
because its isolation is difficult and prolonged (Edwards et al., 1984).
Antigen detection: BRSV was detected in bovine nasal swabs by enzyme
immunosorbent assay designed to detect HRSV (Osorio et al., 1989). BRSV has been
detected using Immunofluorescence in lung tissues from experimentally and naturally
infected calves and nasopharyngeal smears from experimentally infected calves (Thomas
and Stott, 1981). Immunofluorescence also has been used to detect BRSV in lung lavage
samples from epizootics of bovine respiratory tract disease (Kimman et al., 1986).
Serology: Many serological tests have been developed and used in BRSV
diagnosis as complement fixation test (Takashi et al., 1975), microtiter serum
neutralization test (Rossi and Kiesel, 1974), indirect fluorescent antibody test (Potgieter
and Aldridge, 1977), immunodiffusion (Zygraich and Wellemans, 1981), indirect
hemagglutination test (Martin, 1983) and ELISA (Gillette, 1983). Also, ELISA has been
used to detect IgM to BRSV by using monoclonal antibodies to bovine IgM as the
trapping antibody (Westenbrink and Kimman, 1987). A microneutralization ELISA was
developed to detect specific antibodies to BRSV in cattle sera using a monoclonal
antibody to the F protein of the virus (Ellis et al., 1995). Subgroup specific-peptide-based
ELISA were used to determine the prevalence of antibodies against ovine and bovine
subgroup isolates of RSV in cattle (Grubbs et al., 2001).
Reverse transcription-Polymerase chain reaction (RT-PCR) assays :
Reverse transcription-polymerase chain reaction (RT-PCR) assays targeting sequences of
the F protein gene (Oberst et al., 1993; Vilcek et al., 1994; West et al., 1998; Larsen et
al., 1999), G protein gene (Vilcek et al.,1994), nucleoprotein gene (Valarcher et al., 1999)
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have been used to detect BRSV. PCR assays may be more sensitive than IF (Vilcek et al.,
1994; Valarcher et al., 1999) and ELISA (Larsen et al., 1999; Valarcher et al., 1999) and
as specific as IF and ELISA (Valarcher et al., 1999) for the detection of bovine RSV
infections. RT-PCR based on amplifying part of G gene was used to distinguish between
A and B subgroups of HRSV (Gottschalk et al., 1996 ). In a recent study, RT-PCR assay
targeting a specific fragment (426 bp) of F gene has been recommended to differentiate
bovine and ovine RSV (Eleraky et al., 2001).
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Abstract
Ruminant respiratory syncytial viruses are classified into two subgroups, ovine
RSV and bovine RSV. Although ovine RSV infects cattle, its contribution to bovine
respiratory tract disease has not been established which is an important issue for vaccine
development in cattle. Diagnosis by virus isolation or serology has low or variable
sensitivity and/or specificity and PCR has been recommended as a rapid and sensitive
technique for RSV detection. A simple procedure has been developed to detect and
identify bovine and ovine RSVs. First, the nucleotide sequence of the ovine RSV fusion
(F) gene was determined and compared with representative strains of bovine RSV and
human RSV subgroups A and B. The ovine RSV F gene has 85% and 72-73% nucleotide
identity with those of bovine RSV and human RSV respectively. The predicted amino
acid sequence of the ovine RSV F gene has 94% and 83-84% amino acid identity with
those of bovine RSV and human RSV respectively. Then, PCR primers targeting a
specific F gene fragment of bovine and ovine RSV were designed. The primers
represented bases 85-103 and the complementary sequence to bases 510-493 of the ovine
RSV F gene. A similar PCR product (426bp) was obtained on agarose gel
electrophoresis from bovine RSV and from ovine RSV. The products, however, were
unique to the parent virus and could be distinguished by EcoRI or MspI restriction
endonuclease cleavage. EcoRI cleaved the ovine product into 2 bands (285 bp and 141
1bp) but failed to affect the bovine RSV PCR product. However, MspI cleaved the
bovine product into 2 bands (229 bp and 197 bp), but had no effect on the ovine product.
Also, this assay did not amplify any PCR product with human RSV. RT-PCR followed
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by restriction enzyme digestion is a useful and practical approach for detection and
differentiation of ruminant respiratory syncytial viruses.

Introduction
Respiratory syncytial viruses are major causes of severe respiratory tract disease
in young children 5 and calves.7, 26, 14 Ovine RSV was isolated from a one-year-old ewe
with rhinitis.11 RSV also was isolated from an eight-month-old bighorn lamb with
respiratory symptoms.29
Respiratory syncytial viruses are classified in the genus Pneumovirus, which is
included in the family Paramyxoviridae. They are enveloped, single stranded, negativesense RNA viruses that replicate in the cytoplasm and mature by budding from the cell
membrane. The genome is non-segmented, consisting of 10 genes that are transcribed to
10 unique mRNA. Each mRNA encodes a unique protein (NS1, NS2, N, P, M, SH, G, F,
M2, and L).
The G (attachment protein) and F (fusion protein) are the two major surface
glycoproteins encoded by respiratory syncytial viruses. RSV F protein was identified
when F-specific monoclonal antibodies inhibited syncytium formation in cell culture.34
The F glycoprotein is synthesized as an inactive precursor, Fo, that is cleaved by a
cellular protease to generate two disulfide linked subunits, NH2-F2-ss-F1-COOH.10.The
fusion protein may be superior to the attachment protein G in inducing neutralizing
antibodies 22, 36 and cytotoxic T cells.9, 25 Furthermore, the F protein induces fusioninhibiting antibodies that correlate well with protection.30 A conserved neutralization site

53

(173 STNKAVVSLS 182) has been identified on F protein in all known BRSV and
HRSV strains.15
It has been proposed that ruminant RSVs be divided into 2 subgroups, one
representing bovine RSV, and the other representing ovine RSV, based on analysis by
RNAse protection of the G glycoprotein transcripts, 3 nucleotide sequence of ORSV-G
protein gene 2 and reactivity of ruminant RSVs to monoclonal antibodies specific to
BRSV-F protein.24
The predicted BRSV-F protein shares 80.5% overall amino acid identity with the
HRSV F protein with 89% identity within the F1 polypeptide but only 68% identity
within the F2 polypeptide.17 HRSV subgroup B (15837 strain) and subgroup A (A2
strain) have 89% overall amino acid identity of their respective F proteins.13
Experimental infection with ovine RSV in calves resulted in mild to moderate
clinical respiratory disease.8 It has been suggested that two related but antigenically
distinguishable RSV types are present in sheep, one of which is similar to bovine strains
based on differences in fluorescent Ab staining of bovine RSV virus infected cells by
ovine and bovine sera.1 Antibodies specific for either ovine or bovine subgroup strains of
RSV were detected in cattle by using a subgroup-specific G-peptide ELISA, suggesting
that ovine RSV does infect cattle.12
Whether ovine RSV contributes to bovine respiratory disease or not is an
important issue regarding RSV epidemiology and vaccine development in cattle. BRSV
isolation is very difficult because of its lability 28 and viral detection by IF 31 and ELISA
23, 27

are of low or variable sensitivity and specificity. PCR assays may be more sensitive

than IF 33 and ELISA 16 for the detection of BRSV in cattle with acute respiratory disease.
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PCR assays have been recommended as a rapid and sensitive means for detection
of BRSV infection in cattle.33, 21,16 The nucleotide sequence analysis of the ovine RSV F
gene has not been done. In this study, the authors report its nucleotide sequence and its
predicted protein. Based on this information, a PCR test targeting a specific fragment in
the F gene of both bovine RSV and ovine RSV has been developed. The purpose of this
test is to detect both BRSV and ORSV in infected cattle and concurrently to differentiate
between them.

Materials and methods
Nucleotide sequence of F gene and F-M2 intergenic region of ovine RSV:
1- Virus and cells: Ovine respiratory syncytial virus strain WSU 83-1578 a was
grown on Madin Darby Bovine Kidney (MDBK) cells with Dulbeco’s modified Eagles
mediumb supplemented with 2% fetal bovine serum c and antibiotic-antimycotic. c
2- RNA extraction and quantification: Ovine RSV was grown until 50-70%
CPE developed. RNA was extracted with Trizol reagent c according to the protocol of
the manufacturer. In brief, infected cells were collected from a 75-cm2 flask and pelleted
cells were suspended in one ml Trizol and incubated for 5 minutes at room temperature.
Then, after adding 0.2 ml chloroform, incubating for 2-3 minutes at room temperature
and centrifuging at 12,000 xg for 15 minutes at 2-8 oC, the aqueous upper phase was
obtained. RNA was precipitated by adding 0.5 ml isopropyl alcohol, incubating for 10
minutes at room temperature and centrifuging at 12,000 xg for 10 minutes at 2-8 oC. The
RNA pellet then was washed with 1 ml of 75% ethanol and centrifuged at 7,500 xg for 5
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minutes at 2-8 oC. The RNA pellet finally was air dried and dissolved in RNase free
water. The RNA concentration was quantified in a spectrophotometer at A260 wave
length.
3- Primers: Two primers were developed and synthesized c for using in RT-PCR
(figure 1). The F25 primer used for first strand cDNA synthesis
(5’ TGATCTCATATTTGCAGGG 3’) represents the complementary sequence of bases
43-25 of the published sequence of M2 gene of ovine RSV.4 The second primer, F19,
(5’GAGACAAGGGTGTATATAG 3’) representing part of the published intergenic
sequence between F and G genes of ovine RSV 19 was used with the F25 primer for
amplification.
4- First strand cDNA synthesis: Synthesis of cDNA was carried out in 20 ul
reaction volumes by using superscript II Rnase H- reverse transcriptase c according to the
manufacturer’s protocol. Briefly, two picomoles of F25 primer, 4-5 µg of total RNA and
up to 12 µl of water were heated to 70oC for 10 minutes and chilled quickly on ice. Then,
four µl of 5x first strand buffer c, two µl of 0.1 M dithiothritol (DTT) c and one µl of 10
mM dNTP mix c were added and incubated at 42oC for two minutes. One µl (200 units)
of superscript II then was added and incubated at 42 C for 50 minutes followed by
heating at 70 C for 15 minutes to inactivate the reaction.
5- Amplification of ovine RSV F gene and F-M2 intergenic region: Elongase
enzyme mix c was used according to the manufacturer’s directions for amplifying the F
gene of ovine RSV. In brief: For 50 µl-reaction volume, two mixtures were used. Mixture
one consisted of one ul of 10 mM dNTP mix c, one µl of 10 uM F19 primer, 1µl of 10 µM
of F25 primer, one µl of cDNA template and water to 20 ul. Mixture two consisted of two
56
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µl of 5x buffer A c, eight µl of 5x buffer B c, two µl of elongase enzyme mix and water to
30 ul. Mixtures one and two then were gently mixed together in one tube and placed in a
thermal cycler d using the following conditions: denaturation at 95C for 1.5 minutes, then
a three-step cycling program consisting of annealing at 50 oC for 30 seconds, extension at
72 oC for one minute and denaturation at 95 oC for one minute and repeated 30 times. At
the end of the last cycle, the temperature was held at 50 C for two minutes followed by
72 C for 10 minutes.
6- Gel extraction of the PCR product: PCR amplified products were
electrophoresed in 1% agarose gel in 1x TAE buffer. The band representing F gene and
F-M2 region of ovine RSV was extracted from the gel using a gel extraction kit.e
7- Sequencing of the PCR product: Sequencing was done at the University of
Tennessee Molecular Biology Research Facility.f Sequencing was done in both directions
by using the F19 and the F25 primers. The initial sequencing data were used to design
additional primers for sequencing the flanking regions (figure 2 and table 1). This
strategy was repeated to obtain the sequence of the whole product by assembly of
overlapping regions.
Detection of ruminant RSV (bovine and ovine RSV) and differentiation
between them by using RT-PCR: RT-PCR targeting a specific fragment in both
bovine and ovine RSV F genes was used to detect both bovine and ovine RSV and to
differentiate between them.
1- Virus and cells: Ovine respiratory syncytial virus strain WSU 83-1578 a and
bovine respiratory syncytial virus 391-2 g were grown on MDBK cells as described
before. Other isolates of bovine RSV (375 a, FS1-1 a, NMK-7 a, MN i, and NY191285 i),
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Figure 2: Sequencing strategy of ORSV F gene and F-M2 intergenic region
F19 primer was used to get 1a fragment sequence located in the 5’ end and F25 primer
was used to get 2a fragment located in the 3’ end. From 1a and 2a fragments, additional
primers were designed (F238 and F255 from 1a fragment and F410 and F503 from 2a
fragment). This strategy was repeated until sequence of the whole product was obtained
by assembly of overlapping regions. 1a, 1b, 1c, 1d, 1e, 1f, 1g, 2a, 2b and 2c represent the
overlapping fragments. The primers used for sequencing of each fragment are between
parentheses. The arrows indicate the direction of amplification.
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Table 1: Primers used for sequencing of ORSV F gene and F-M2 intergenic region
Primers used to sequence the positive

Primers use to sequence the negative sense

sense regions (1a, 1c, 1d, 1f, 1g and 2c)

regions (2a, 2b, 1e and 1b)

F19 (GAGACAAGGGTGTATATAG)

F25 (TGATCTCATATTTGCAGGG)

F255 (AGCAGTACTGATTCAAAGG)

F410 (CACTAAGCTGATCTTTTCC)

F244 (TTCTCACTAGCAAAGTGC)

F59 (AGGCATATCATTAATCAGTG)

F738 (GAATTTAGTATAAATGCTGG )

F238 (ACCTTTGAATCAGTACTGC)

F462 (TACTGCCAAATATGACTGC)
F503 (CATGATCTGAACCTCAAAC)
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human RSV subgroup A (strain A2 g), and human RSV subgroup B (strain B8/60 g) were
included in the study. Human RSV strains were grown on vero cells.
1- RNA extraction and quantification were done as described above.
2- Primers: Two primers were developed and synthesized.c The F103 primer
(5’ TGCCAAAACATAACAGAAG 3’) was used for cDNA synthesis. It represents a
conserved sequence in both ovine and bovine RSV F genes; bases 85-103 of ovine RSV
F gene (determined in this study) and bases 86-104 of bovine RSV F gene.17 The other
primer; F493 (5’ TTTATTCACCTCTCCCTC 3’) represents a conserved sequence in
both ovine and bovine RSV F genes. It is complementary to bases 510-493 of the ovine
RSV F gene (determined in this study) and bases 511-494 of bovine RSV F gene.17 These
primers (F493 and F103) were used for amplification of specific fragment of F genes of
both bovine and ovine RSV.
3- PCR: Taq DNA polymerase c was used for amplification of a 426 bp fragment
of F gene of both bovine and ovine RSV according to the manufacturer’s
recommendations. In brief, the following components were added for a final reaction
volume of 100 µl: Ten µl of 10x PCR buffer c, three µl of 50 mM Mgcl2 c , two µl of 10
mM dNTP mix c, one µl of 10 uM F 493 primer, one µl of 10uM F103 primer, one µl taq
DNA polymerase , two µl of cDNA and 80 µl of water. Amplification was done using the
same conditions mentioned before except using of 58oC for annealing instead of 50oC.
4- Restrictiction enzyme cleavage and electrophoresis: EcoRI c and MspI c
restriction enzymes were used separately to cleave each of the 426 bp amplified products
of bovine and ovine RSV F genes. Four µl of unpurified PCR product, four µl of water,
one µl of the restriction enzyme used and one µl of the buffer supplied with the enzyme
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were added together and incubated for one hour at 37 C. After incubation, electrophoresis
was done using three percent high-resolution agarose.h

Results
Nucleotide sequence of the ovine RSV F gene and F-M2 intergenic region:
Figure 3 shows the PCR product representing the F gene, the F-M2 intergenic
region and the M2 gene 5’ end of ovine RSV. After extraction of this, approximately
2000 bp, PCR product from the gel, its sequence was determined (Fig. 4).
A comparison of this sequence (Gene Bank accession number AF334398) with
representative published sequences of bovine RSV and human RSV F genes 13,17, 18
indicated that the sequence from 1-1896 bases most likely represents the F gene of ovine
RSV (Fig.4a) and the sequence from 1897-1955 bases represents F-M2 intergenic region
(Fig.4b). The sequence from 1956- 1992 bases was identical to bases 1-37 of the 5’ end
of the published sequence of M2 gene of ovine RSV.4 The ovine RSV F gene has 85%,
73% and 72% nucleotide identity with those of bovine RSV, 17 human RSV subgroup A
18

and human RSV B subgroup 13 respectively (Fig.4a and Table 2). The coding sequence

of ovine RSV gene, represented by bases 13-1737, is more conserved than the noncoding sequence (1738-1896). However, the 3’ end of the non-coding region (bases
1887-1896) is highly conserved (Fig.4a and Table 2).
The open reading frame of ovine RSV F gene predicts a polypeptide of 574 amino
acids. The predicted amino acid identity between the F protein of ovine RSV and those of
bovine RSV, 17 human RSV subgroup A 18 and human RSV subgroup B 13 is 94%, 83%
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Figure 3: The PCR product representing the ovine RSV F gene, the F-M2 intergenic
region and the 5’ end of the M2 gene (1992 bp) is in lane B. The 250 bp DNA ladder is in
lane A.
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Figure 4: Nucleotide sequence of ovine RSV F gene and F-M2 intergenic region and
comparison with other RSVs.
(a) Comparison of nucleotide sequence of ovine RSV F gene strain WSU 83-1578 with
those of bovine RSV (strain 391-2), human RSV(A) Long strain and human RSV(B)
strain 18537. The dots above the sequence are spaced every 10 nucleotides and the
number of the last nucleotide for each line is given on the right end of the line. Only the
non-identical bases are indicated for the bovine and human RS viruses. (b) Nucleotide
sequence of F-M2 intergenic region (1897-1955)and the M2 gene 5’ end (1956-1992).
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TA C A A TAT..TT A ATCATAGCA GG TGAATCATTTC CAT T TG T 1857
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HRSV
HRSV

.
.
.
(83-1578) CCATACATGCTACATTTAGCTTCATGTCCATAGTTATAT 1896
(391-2)
T
C C
C
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TTACAC AT TA G AGAT C TA TT
1899
(18537)
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C
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.
.
.
.
.
.
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A
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G
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T
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G C G
C
AG AT G ATCA A
A T T
G G T C AG C
AC
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(b)
.
.
.
.
.
.
AAAAATGTTATAATAGCACCCCATAATTGAACAAATTAATGACCAACCAATTAGAAAGTG 1956
.
.
.
.
.
.
GGGCAAATATGTCACGAAGAAATCCCTGCAAATATG 1992
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Table 2: Percentage of nucleotide identity among F protein genes of respiratory syncytial
viruses [ORSV strain WSU 83-1587, BRSV strain 391-2, HRSV (A) Long strain and
HRSV (B) strain 18537]
ORSV

ORSV

ORSV

BRSV

BRSV

X

X

X

X

X

HRSV (A)
X

BRSV

HRSV (A)

HRSV (B)

HRSV (A)

HRSV (B)

HRSV (B)

77

43

44

37

36

61

F2

83

72

73

73

71

82

F1

88

79

78

78

78

84

Coding

87

76

75

75

75

82

67

46

45

45

38

53

85

73

72

73

72

80

Signal
peptide

sequences
Noncoding
sequence
Overall F
gene
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Fig. 5: Comparison of the predicted amino acids of the ORSV F protein with those of
BRSV strain 391-2, HRSV (A) Long strain and HRSV (B) strain 18537. The dots above
the sequence are spaced every 10 amino acids and the number of the last amino acid for
each line is shown to be the right end of the line. Only the non-identical amino acids are
indicated for the bovine and human RS viruses. The amino terminal hydrophobic domain
(presumptive signal peptide) and the carboxy terminal domain (membrane anchorage
domain) are underlined. The hydrophobic sequence at the N terminus of F1 is denoted by
double underline. Potential N-linked glycosylation sites are highlighted and cysteine
residues are indicated by solid triangles.
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Table 3: Percentage of amino acid identity among F proteins of respiratory syncytial
viruses. [ORSV strain WSU 83-1587, BRSV strain 391-2, HRSV (A) Long strain and
HRSV (B) strain 18537]
ORSV

ORSV

ORSV

BRSV

BRSV

X

X

X

X

X

HRSV (A)
X

BRSV

HRSV (A)

HRSV (B)

HRSV (A)

HRSV (B)

HRSV (B)

56
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8

4

12

40

F2

89

70

70

68

68

87

F1

97

89

89

89

89

93

F protein

94

82

82

81

82

90

Signal
peptide
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and 84% respectively (Fig. 5 and Table 3).
The ovine RSV F1 subunit has 97% and 89% amino acid identity with those of
bovine RSV 17 and human RSV A&B 18, 13 respectively, whereas the F2 subunit identity is
somewhat lower, 89% and 70%, respectively (Fig. 5 and Table 3). The predicted signal
peptide amino acid sequence of ovine RSV F protein shows extensive divergence from
those of bovine and human RSV (Fig. 5 and Table 3). The positions of cysteine residues
in ovine RSV F protein are conserved with respect to bovine and human RSV except in
one position (residue 25), which is conserved only in ovine and bovine RSV (Fig. 5).
Amino acid residues 131-136 in the ovine RSV F protein sequence is identical to the
proposed cleavage signal in bovine and human RSV F proteins.17, 13 Hydrophobic
residues (137-158) likely represent the proposed amino terminus of F1 subunit after
cleavage, while hydrophobic residues 525-550 may represent the proposed membrane
anchor. Three potential sites for N-linked glycosylation have been found in the predicted
ovine RSV F protein; 2 in F2 subunit (residues 27 and 120) and one in F1 subunit
(residue 500) (Fig. 5).
Detection of ruminant RSV and differentiation between its two subgroups:
An RT-PCR assay targeting the F gene resulted in amplification of a 426 bp
product in both bovine and ovine RSV (Fig. 6). Nucleotide sequencing of both products
(data not given) confirmed the fidelity of this PCR assay. Digestion of both products by
EcoRI restriction endonuclease cleaved the ovine PCR product into 2 bands (285 bp and
141 bp), but did not affect the bovine product (Fig.6). In contrast, MspI restriction
endonuclease cleaved the bovine PCR product into 2 bands (229 bp and 197 bp), but had
no effect on the ovine product (Fig.6).
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Figure 6: Detection of bovine and ovine RSV and differentiation between them by RTPCR followed by restriction enzyme cleavage. Lane A contains the 50 bp DNA ladder.
Lanes B and C represent the PCR products obtained from ovine and bovine RSV
respectively (426 bp). Lane D contains the cleavage products (285 bp and 141 bp) of the
ovine RSV PCR product after EcoRI treatment. Lane E contains the bovine RSV PCR
product (426 bp) after EcoRI treatment. The ovine RSV PCR product (426 bp) after MspI
treatment is represented in lane F. Cleavage products of the bovine RSV PCR product
(229 bp and 197 bp) after MspI treatment are in lane G.
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All bovine RSV isolates tested (375, FS1-1, NMK-7, MN, and NY191285 ) gave
the same PCR product and the same cleavage pattern obtained with bovine RSV strain
391-2. All of these bovine isolates could be differentiated from the ovine RSV. No PCR
products resulted when human RSV subgroup A (strain A2), and human RSV subgroup B
(strain B8/60) were used in the assay.

Discussion
Ovine RSV F gene has 85% and 72-73% nucleotide identity with those of bovine
RSV and human RSV respectively. The predicted amino acid sequence of the ovine RSV
F gene has 94% and 82% amino acid identity with those of bovine RSV and human RSV
respectively.
The level of identity between ovine and bovine RSV F genes (85%) and their
predicted proteins (94%) are close to those found between the two human subgroups A
and B, 80% nucleotide identity and 90% amino acid identity (Table 2 and 3). This
supports the existence of two ruminant subgroups, one representing bovine RSV and the
other representing ovine RSV.3, 2, 24
The level of identity between ovine and human RSV F predicted proteins (82%) is
similar to that found between bovine and human RSV (81-82%). The positions of the 3
potential N-linked glycosylation sites in ovine RSV F predicted protein coincide with that
found in bovine and human RSV.17, 13 But, human RSV strains have 2-3 additional sites
in the F2 peptide.13, 6 The difference in the extent of glycosylation of F2 is responsible for
the difference in electrophoretic mobility of F2. 17,20
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A novel neutralization site (residues 173-182) has been mapped in bovine RSV F
protein by using a neutralizing monoclonal antibody against F protein.15 This site is
conserved in the ovine sequence as well as in the human RSV F proteins (Fig. 5). This
conserved linear epitope may be a potential candidate for peptide-based vaccine against
all groups and subgroups of RSV.15
PCR assays have been used in several studies for detection of bovine RSV. 33, 21,
35, 32, 16.

In one study specific bovine RSV primers amplified bovine RSV strains, but did

not amplify ovine RSV. PCR assay used in a previous study was able to detect the bovine
RSV, but not the ovine RSV.21 It has been found that ovine RSV does infect cattle.12 The
PCR assay described in the present study has the capacity to detect both bovine and ovine
RSV by using one set of primers and subsequent differentiation between them by a
simple procedure.
The two primers used in this PCR assay represent conserved sequences in ovine
and bovine RSV F genes that are not conserved in the human RSV F gene. This allowed
clear differentiation between ruminant RSV and human RSV. RSV PCR assays depend
upon detection of viral RNA or mRNA transcripts that are present in active infections,
whereas serological tests depend upon detection of antibodies, which develop during the
convalescent phase of infection. Therefore, an advantage of PCR tests over serological
tests is that earlier detection of infection is possible. Also, conventional serological
diagnosis is dependent upon paired serum samples taken during the acute and
convalescent phases of the disease and, unlike the PCR test in the present study, are not
capable of discriminating between the ruminant RSV subgroups. This PCR test can by
used to detect both bovine and ovine RSV in cattle and may be useful for determining the
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contribution of ovine RSV in the pathogenesis of bovine respiratory tract disease.
Moreover, data from some previous studies indicated that PCR assays are more sensitive
than IF 33 and ELISA 16 for the detection of BRSV antigen.

Sources and manufacturers
a. Provided by Dr Howard Lehmkuhl, National Animal Disease Laboratory, Ames, Iowa.
b. Bio-Whittaker, Walkersville, MD.
c. Gibco-BRL, Gaithersburg, MD.
d. Perkin Elmer Gene Amp PCR system 9600, Perkin Elmer Inc., Norwalk, CA.
e. QIA quick gel extraction kit, Qiagen Inc., Valencia, CA.
f. Using an ABI prism dye terminator cycle sequencing reaction kit and an ABI 373 DNA
sequencer, Perkin Elmer Inc., Foster city, CA.
g. Provided by Dr. Gail Wertz, Dept. of Microbiology, Univ. of Alabama Medical
School, Birmingham, AL.
h. Sigma Chemicals Co., St. Louis, MO.
i. Provided by Dr. John Baker, Department of Large Animal Clinical Sciences, College of
Veterinary Medicine, Michigan State University, East Lansing, Michigan.
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Part III

RT-PCR for simultaneous detection of bovine and ovine
respiratory syncytial viruses

83

Abstract
Whether ovine RSV contributes to bovine respiratory disease is relevant to the
complete understanding of RSV epidemiology and vaccine development in cattle and
sheep. Currently a laboratory test to differentiate between bovine and ovine RSVs does
not exist. Two RT-PCR assays have been developed for simultaneous detection of bovine
and ovine respiratory syncytial viruses. One, a set of primers amplified a 426 bp fragment
of either bovine or ovine RSV F gene (RT-PCR F). PCR-F products could be
distinguished by EcoRI or BstYI restriction endonuclease cleavage. In the other assay, a
set of primers amplified a 542 bp fragment of either ovine or bovine RSV G gene (RTPCR G). EcoO109I and RsaI restriction enzymes were used to differentiate between the
ovine and bovine PCR-G products. Sequencing of the PCR products confirmed the
fidelity of both assays. The two assays were evaluated using eight bovine RSV isolates,
one ovine RSV, one bighorn sheep RSV, one caprine RSV, two human RSV isolates and
several viruses associated with bovine respiratory tract disease. The two PCR assays
described in this study potentially constitute sensitive and specific means for
simultaneous detection of bovine and ovine RSV and differentiation between them.
However, RT-PCR F followed by the appropriate restriction enzyme cleavage may be
superior to RT-PCR G to discriminate between the two ruminant RSV subgroups and for
determining the relative contribution of ovine and bovine RSV to the pathogenesis of
bovine respiratory tract disease. This is relevant to the complete understanding of RSV
epidemiology and immunoprophylaxis.

Keywords: RSV; diagnosis; PCR
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Introduction
Respiratory syncytial viruses (RSVs) are major causes of severe respiratory tract
disease in young children (Avila et al., 1989) and calves (Bryson et al., 1978; Pirie et
al.,1981; Kimman et al., 1988). Ovine RSV was isolated from a one-year-old ewe with
rhinitis (Evermann et al., 1985). Bighorn sheep RSV was isolated from respiratory
disease outbreak in a captive herd of Bighorn sheep (Evermann et al., 1994).
Respiratory syncytial viruses are classified in the genus Pneumovirus, which is
included in the family Paramyxoviridae. The G (attachment protein) and F (fusion
protein) are the two major surface glycoproteins encoded by respiratory syncytial viruses.
The ovine RSV F gene and its encoded protein have 85% nucleotide identity and
94% amino acid identity with that of bovine RSV (Eleraky et al., 2001). While, the ovine
RSV G gene and its encoded protein share 70% and 62% nucleotide and amino acid
identity to the equivalent gene and its encoded protein, respectively, of bovine RSV
(Alansari and Potgieter, 1993).
It has been proposed that ungulate RSVs be divided into 2 subgroups, one
representing bovine RSV, and the other representing ovine RSV, based on analysis of
ruminant RSVs by RNAse protection of the G glycoprotein transcripts (Alansari et al.,
1999), nucleotide sequence of ORSV-G protein gene (Alansari et al., 1993) and reactivity
of ungulate RSVs to monoclonal antibodies specific to BRSV-F protein (Pastey and
Samal, 1997).
Experimental infection with ovine RSV in calves resulted in mild to moderate
clinical respiratory disease (Bryson et al., 1988). It has been suggested that two related
but antigenically distinguishable RSV types are present in sheep, one of which was
85

similar to bovine strains and the other had a different fluorescence pattern (Adair and
McFerran, 1987). Antibodies specific for either ovine or bovine subgroup strains of RSV
were detected in cattle by using a subgroup-specific G-peptide ELISA, suggesting that
ovine RSV also infects cattle (Grubbs et al., 2001).
Whether ovine RSV contributes to bovine respiratory disease or not is relevant to
the complete understanding of RSV epidemiology and vaccine development in cattle and
sheep. BRSV isolation is difficult because of its lability (Smith et al., 1974). PCR assays
may be more sensitive than IF (Vilcek et al., 1994; Valarcher et al., 1999) and ELISA
(Larsen et al., 1999; Valarcher et al., 1999) and as specific as IF and ELISA (Valarcher et
al., 1999) for the detection of bovine RSV infections. PCR assays have been
recommended for diagnosis of bovine RSV infection in cattle (Oberst et al., 1993; Vilcek
et al., 1994; Valarcher et al., 1999; Larsen et al., 1999).
Currently a laboratory test to differentiate between bovine and ovine RSVs does
not exist. We developed and evaluated two PCR assays; one targeting the F gene (RTPCR F) and the other targeting the G gene (RT-PCR G) of bovine RSV and ovine RSV to
simultaneously detect bovine and ovine RSV and concurrently to differentiate between
them.

Materials and Methods
Viruses and cells: Ovine respiratory syncytial virus isolate WSU 83-1578
(Provided by Dr Howard Lehmkuhl, National Animal Disease Laboratory, Ames, Iowa)
and bovine respiratory syncytial virus 391-2 (Provided by Dr. Gail Wertz, Dept. of
Microbiology, Univ. of Alabama Medical School, Birmingham, AL) were used to
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inoculate Madin Darby Bovine Kidney (MDBK) cells grown with Dulbeco’s modified
Eagles medium supplemented with 2% fetal bovine serum.
RNA extraction and quantification: Ovine and bovine RSV were grown until a
50-70% cytopathic effect developed. RNA was extracted with Trizol reagent (GibcoBRL, Gaithersburg, MD) according to the protocol of the manufacturer. In brief, infected
cells were collected from a 75-cm2 flask, and suspended in one ml Trizol and incubated
for 5 minutes at room temperature. Then, after adding 0.2 ml chloroform, incubating for
2-3 minutes at room temperature and centrifuging at 12,000 xg for 15 minutes at 2-8 oC,
the aqueous upper phase was obtained. RNA was precipitated by adding 0.5 ml isopropyl
alcohol, incubating for 10 minutes at room temperature and centrifuging at 12,000 xg for
10 minutes at 2-8 oC. The RNA pellet then was washed with 1 ml of 75% ethanol and
centrifuged at 7,500 xg for 5 minutes at 2-8 oC. The RNA pellet then was air dried and
dissolved in Rnase-free water. The RNA concentration was quantified in a
spectrophotometer at A260 wavelength.
Primers for RT-PCR F: Two primers were developed and synthesized (GibcoBRL, Gaithersburg, MD) for amplification of a 426 bp F gene fragment of bovine and
ovine RSV (Fig. 1). The F103 primer (5’TGCCAAAACATAACAGAAG 3’) was used
for cDNA synthesis. It represents a conserved sequence in ovine and bovine RSV F genes
[bases 85-103 of ovine RSV F gene (Eleraky et al., 2001) and bases 86-104 of bovine
RSV F gene (Lerch et al., 1991)]. The other primer, F493
(5’ TTTATTCACCTCTCCCTC 3’), represents also a conserved sequence in ovine and
bovine RSV F genes. It is complementary to bases 510-493 of the ovine RSV F gene
(Eleraky et al., 2001) and bases 511-494 of bovine RSV F gene (Lerch et al., 1991).
87

88

89

Primers for RT-PCR G: Another set of primers, derived from the published
sequence of ovine RSV G gene (Alansari and Potgieter, 1993), was synthesized and used
for amplification of 542 bp G gene fragment of ovine and bovine RSV (Fig. 2). One
primer [G164 (5’ AGCCCTAGCAATGATAAC 3’)] representing bases 147-164 of
ovine RSV G gene was used for cDNA synthesis. The second primer [G672 (5’
GACTGGTTCTGTGGTGG 3’)] represents the complementary sequence of bases 688672 of the ovine RSV G gene.
First strand cDNA synthesis: Synthesis of cDNA was done in 20 µl reaction
volumes by using superscript II Rnase H- reverse transcriptase (Gibco-BRL,
Gaithersburg, MD) according to the manufacturer’s protocol. Briefly, two pico moles of
the specific primer, 4-5 µg of total RNA and up to 12 µl of water were heated to 70oC for
10 minutes and chilled quickly on ice. Then, four µl of 5x first strand buffer (Gibco-BRL,
Gaithersburg, MD), two µl of 0.1 M DTT (Gibco-BRL, Gaithersburg, MD) and one µl of
10mM dNTP mix (Gibco-BRL, Gaithersburg, MD) were added and incubated at 42oC for
two minutes. One µl (200 units) of superscript II then was added and incubated at 42 C
for 50 minutes followed by heating at 70 C for 15 minutes to inactivate the reaction.
PCR: In brief, the following components were mixed for a final reaction volume
of 100 µl: ten µl of 10x PCR buffer (Gibco-BRL, Gaithersburg, MD), three µl of 50 mM
Mgcl2 (Gibco-BRL, Gaithersburg, MD), two µl of 10 mM dNTP mix (Gibco-BRL,
Gaithersburg, MD), one µl of 10 uM of each specific primer, one µl taq DNA polymerase
(Gibco-BRL, Gaithersburg, MD), two µl of cDNA and 80 µl of water. Amplification was
done under the following conditions: denaturation at 95oC for 1.5 minutes, then a threestep cycling program (repeated 30 times) consisting of annealing at 58oC for 30 seconds,
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extension at 72oC for one minute and denaturation at 95oC for one minute followed by
holding the temperature at 50oC for two minutes and then 72oC for 10 minutes.
Sequencing of the PCR products: Sequencing was done at the University of
Tennessee Molecular Biology Research Facility by using an ABI prism dye terminator
cycle sequencing reaction kit and an ABI 373 DNA sequencer, Perkin Elmer Inc., Foster
City, CA.
Restrictiction enzyme cleavage and electrophoresis: EcoRI (Gibco-BRL,
Gaithersburg, MD), and BstYI (New England BioLabs, Beverly, MA) restriction
enzymes were used separately to cleave each of the 426 bp-amplified products (PCR F)
of ovine and bovine RSV F genes. EcoO109I and RsaI restriction enzymes (Gibco-BRL,
Gaithersburg, MD) were used separately to cleave each of the 542 bp PCR products
(PCR G) of bovine and ovine RSV G genes. Four µl of unpurified PCR product, four ul
of water, one µl of the restriction enzyme used and one µl of the buffer supplied with the
enzyme were mixed together and incubated for one hour at 37 oC except with BstYI (60
o

C). After incubation, electrophoresis was done in three percent high-resolution agarose

(Sigma Chemicals Co., St. Louis, MO).
Evaluation studies:The two assays were evaluated with the following additional
RSV isolates: bovine RSV (isolates 375, FS1-1, NMK7, MN, CA, NY191285 and
1156R), caprine RSV, Bighorn sheep RSV isolate (WSU 87-6750), human RSV
subgroup A (strain A2), human RSV subgroup B (strain B8/60). These isolates kindly
were provided by Dr Howard Lehmkuhl, National Animal Disease Laboratory, Ames,
Iowa; Dr. Gail Wertz, Dept. of Microbiology, University of Alabama Medical School,
Birmingham, AL; Dr. John Baker, Department of Large Animal Clinical Sciences,
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College of Veterinary Medicine, Michigan State University, East Lansing, MA; and Dr.
James Evermann, Washington Animal Disease Diagnostic Laboratory, Pullman, WA.
Also, they were tested with several viruses associated with bovine respiratory tract
disease including bovine herpesvirus 1, bovine parainfluenza 3, bovine virus diarrhea
virus, bovine coronavirus, and bovine adenovirus 3. These strains were provided by the
Clinical Virology Laboratory, College of Veterinary Medicine, University of Tennessee,
Knoxville, TN. MDBK line cells were used for growing of bovine RSV strains, bovine
herpesvirus 1, bovine parainfluenza 3, bovine virus diarrhea virus and bovine adenovirus
3. HRT line cells were used for growing of bovine coronavirus. Secondary goat turbinate
cells and VERO line cells were used for growing of caprine RSV and human RSV
respectively.
Also, the two RT-PCR assays were done using decreasing amounts of total RNA
extracted from infected cells (4 µg, 2 µg, 1 µg, 0.5 µg, 0.25 µg, 0.13 µg, 0.06 µg and 0.03
µg)

Results
RT-PCR F: The RT-PCR assay targeting the F gene resulted in amplification of a
426 bp (PCR F) with ovine RSV strain WSU 83-1578 and bovine RSV strain 391-2 (fig.
3B, 3c). Nucleotide sequencing of both products confirmed the fidelity of this assay (Fig.
4). Digestion of both products by EcoRI restriction endonuclease cleaved the ovine PCR
product into 2 bands, 285 bp and 141 bp (fig. 3D) but did not affect the bovine product
(fig.3E). In contrast, BstYI restriction endonuclease cleaved the bovine PCR product into
2 bands, 361 bp and 65 bp (fig. 3F), but had no effect on the ovine product (fig. 3G).
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Figure 3: RT-PCR F followed by restriction enzyme cleavage. Lane A contains the 50 bp
DNA ladder. Lanes B and C represent the PCR F products obtained from ovine and
bovine RSV respectively (426 bp). Lane D contains the cleavage products (285 bp and
141 bp) of the ovine RSV PCR F product after EcoRI treatment. Lane E contains the
bovine RSV PCR F product (426 bp) after EcoRI treatment. The ovine RSV PCR F
product (426 bp) after BstyI treatment is represented in lane F. Cleavage products of the
bovine RSV PCR F product (361 bp and 65 bp) after BstyI treatment are in lane G.
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a)
1

CAATCAACAT GTAGTGCAGT TAGTAGAGGT TATCTCAGTG CATTACGAAC

51

TGGATGGTAC ACAAGTGTGG TGACAATAGA ATTGAGCAAC ATACAAAAAA

101

ATGTATGTAG CAGTACTGAT TCAAAGGTAA AATTGATAAA GCAAGAGTTA

151

GAAAGATATA ATAATGCAGT AGCTGAGTTA CAGTTGCTCA TGCAAAATAC

201

ACCGTCTATC ACCAACAGGG CCAAAAGAGG AATATCAGAG TTGGTTCACT

251

ATACAAAGAA TTCCACTAAG AGATTTTATG GTCTAATGGG CAAAAAAAGA

301

AAAAGGAGGT TCTTAGGGTT CTTGCTTGGT ATAGGGTCTG CTATTGCGAG

351

TGGAATAGCA GTGTCTAAAG TATTACATTT AGAGGGAGAG GTG

b)
1

CAATCAACAT GCAGTGCAGT TAGTAGAGGT TATCTTAGTG CATTAAGAAC

51

TGGATGGTAT ACAAGTGTAG TAACAATAGA GTTGAGCAAA ATACAAAAGA

101

ATGTGTGTAA AAGTACTGAT TCAAAAGTGA AATTAATAAA GCAAGAACTG

151

GAAAGATACA ACAATGCAGT AATAGAATTG CAGTCACTTA TGCAAAATGA

201

ACCGGCTTCC TTCAGTAGAG CAAAAAGAGG GATACCAGAG TTGATACATT

251

ATACAAGAAA CTCTACAAAG AGATTTTATG GGTTAATGGG CAAGAAGAGA

301

AAGAGGAGAT TTTTAGGATT CTTGCTAGGT ATTGGATCTG CTGTTGCAAG

351

TGGTGTAGCA GTGTCCAAAG TACTACACCT GGAGGGAGAG GTGAATAAAA

Figure 4: Nucleotide sequence of the amplified PCR F products of ovine RSV (a) and
bovine RSV (b).
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RT-PCR G: The PCR assay targeting the G gene resulted in production of a 542
bp (PCR G) product with ovine RSV strain WSU 83-1578 and bovine RSV isolate 391-2
(fig.5B, 5C). Sequencing of the PCR products confirmed the fidelity of this assay (Fig.
6). EcoO109I treatment resulted in production of two bands, approximately the same size
(275 bp and 267 bp) with the ovine RSV product only (fig.5D) and did not affect the
bovine RSV product (fig.5E). RsaI treatment produced two bands (391 bp and 151 bp)
with the bovine RSV product only (fig.5G) and had no effect on ovine RSV (fig. 5F).
Evaluation studies: All bovine RSV isolates tested (375, FS1-1, NMK7, MN,
CA, NY191285 and 1156R) were successfully amplified by the two assays and gave the
same cleavage pattern obtained with bovine RSV strain 391-2. All of these bovine
isolates could be differentiated from ovine RSV by RT-PCR F and RT-PCR G followed
by the appropriate restriction enzyme treatment (Table 1). The caprine RSV gave the
same pattern obtained with the bovine RSV isolates with both PCR assays and was
differentiated from the ovine RSV (Table 1). Amplification products resulted with the
bighorn sheep RSV isolate WSU 87-6750 in the two assays. However, the RT-PCR F
product yielded the same cleavage pattern as with ovine RSV isolate WSU 83-1578 with
EcoRI, but the RT-PCR G product was not cleaved with EcoO109I or RsaI (Table 1).
No PCR products resulted in either assay with human RSV subgroup A (strain A2),
human RSV subgroup B (strain B8/60), bovine herpesvirus 1, bovine parainfluenza virus
3, bovine virus diarrhea virus, bovine coronavirus or bovine adenovirus 3 (Table 1).
PCR F and PCR G products with ovine and bovine RSV isolates were detected by using
as little as 0.06 µg and 0.03 µg respectively of total RNA (Table 2).
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Figure 5: RT-PCR G followed by restriction enzyme cleavage. Lane A contains the 50
bp DNA ladder. Lanes B and C represent the PCR G products obtained from ovine and
bovine RSV respectively (542 bp). Lane D contains the cleavage products of the ovine
RSV PCR G product having approximately the same size (275 bp and 267 bp) after
EcoO109I treatment. Lane E contains the bovine RSV PCR G product (542 bp) after
EcoO109I treatment. The ovine RSV PCR G product (542 bp) after RsaI treatment is
represented in lane F. Cleavage products of the bovine RSV G product after RsaI
treatment (391 bp and 151 bp) are in lane G.
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a)
1

CTTACCATAA CAGCCATCAT TTATATTAGC ACAGGAAACA CAAAAGCCAA

51

ACCCATGCCT ACACCAACAA TTCAGATCAC CCAACAGTTC CAAAACCACA

101

CCTCTCTGCC TCCCACAGAA CACAACCATA ACTCTACTCA CTCTCCAACT

151

CAAGGCACCA CATCACCCCA CACTTTCGCC GTAGATGTCA CCGAAGGAAC

201

TGCATACTAC CACTTGACCC ACAAAACTCA AGGCGGTAAA ACCAAAGGCC

251

CTCCTACTCC ACATGCCACA AGGAAACCCC CCATCAGTTC ACAGAAGAGC

301

AATCCCTCCG AAATTCAACA AGATTACAGT GACTTTCAAA TACTTCCCTA

351

TGTGCCCTGC AACATATGTG AAGGTGACTC TGCTTGTTTA TCCCTCTGTC

401

AAGATAGATC CGAGAGCATA CTGGATAAAG CTCTAACAAC CACCCCCAAA

451

AAAACTCCAA AACCCATGAC CACCAAAAAG CCAACC

b)
1

CATCACTCGT CATCACAGCC ATTATTTACA TTAGTGTGGG AAATGCTAAA

51

GCCAAGCCCA CATCCAAACC AACCATCCAA CAAACACAAC AGCCCCAAAA

101

CCATACCTCA CCATTTTTCA CAGAGCACAA CTACAAATCA ACTCACACAT

151

CAATTCAAAG CACCACACTG TCCCAACTAC TAAACATAGA CACTACTAGA

201

GGAATTACAT ATGGTCACTC AACCAACGAA ACCCAAAACA GAAAAATCAA

251

AGGCCAATCC ACTCTACCCG CCACCAGAAA ACCACCAATC AATCCATCGG

301

GAAGCATCCC CCCTGAAAAC CATCAAGACC ACAACAACTT CCAAACACTC

351

CCCTATGTGC CTTGCAGTAC ATGTGAAGGT AATCTTGCTT GCTTATCACT

401

CTGCCATATT GAGACGGAGA GAGCACCAAG CAGAGCCCCT ACAATCACCC

451

TCAAAAAGAC TCCAAAACCC AAAACCACTA AAAAGCCAAC CAAGA

Figure 6: Nucleotide sequence of the amplified PCR G products of ovine RSV (a) and
bovine RSV (b).
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Table 1: Evaluation of the potential specificity RT- PCR F and RT-PCR G

PCR F

Bovine

426 bp

PCR F +

PCR F +

EcoRI

BstYI

426 bp

361 bp,

RSV

PCR G

542 bp

PCR G +

PCR G +

EcoO109I

RsaI

542 bp

391 bp,

65 bp

151 bp

8 strains§
Caprine

426 bp

426 bp

RSV
Ovine

542 bp

542 bp

65 bp
426 bp

RSV
Bighorn

361 bp,

285bp,

426 bp

151 bp
542 bp

141 bp
426 bp

sheep

285 bp,

391 bp,

275 bp,

542 bp

267 bp
426 bp

542 bp

542 bp

542 bp

141 bp

RSV
Human

No

No

RSV

product

product

Other

No

No

viruses*

product

product

(A&B)

§ 391-2, 375, FS1-1, NMK7, MN, CA, NY191285 and 1156R
* Viruses associated with bovine respiratory tract disease; bovine parainfluenza virus 3,
bovine herpesvirus 1, bovine virus diarrhea virus, bovine coronavirus, and bovine
adenovirus
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Table 2: Evaluation of the potential sensitivity of RT-PCR F and RT-PCR G assays

Total RNA used

PCR F product

PCR G product

4 µg

+

+

2 µg

+

+

1 µg

+

+

0.5 µg

+

+

0.25 µg

+

+

0.13 µg

+

+

0.06 µg

+

+

0.03 µg

No product

+
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Discussion
PCR assays have been used in several studies for detection of bovine RSV
(Oberst et al., 1993; Vilcek et al., 1994; Valarcher et al., 1999; Larsen et al., 1999). In the
present study, the bovine RSVs tested (8 isolates from different sources) reacted
identically and could be differentiated from ovine RSV in both PCR assays described in
this study. Moreover, no PCR products were detected with human RSV, bovine
parainfluenza virus 3, bovine herpesvirus 1, bovine virus diarrhea virus, bovine
coronavirus, and bovine adenovirus in these two assays.
BstyI used in cleavage of bovine RSV F products in this study may be superior to
MspI used in a previous study (Eleraky et al., 2001). BstyI cleaved all the PCR F
products obtained from the eight bovine RSV isolates, but some isolates (CA and 1156R)
resisted cleavage by MspI. The MspI target sequence does not appear to be well
conserved (data not shown).
Caprine RSV gave the same pattern as bovine RSV did in both assays and could
be differentiated from ovine RSV. This confirms previous studies suggesting that caprine
RSV is closely related to bovine RSV isolates (Alansari et al., 1999).
Nucleotide sequencing of amplified fragments of F and G genes of Bighorn sheep
isolate WSU 87-6750 (data not shown) indicated very high level of identity with ovine
RSV isolate WSU 83-1578 suggesting that the Bighorn RSV may be considered a
member of the ovine RSV subgroup. However, unlike ovine RSV isolate WSU 83-1578,
the bighorn sheep RSV strain WSU 87-6750 resisted cleavage using EcoO109I following
RT-PCR G due to a point mutation in the cleavage site (data not shown), but they had the
same cleavage pattern with EcoRI of their respective F gene amplified products.
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It has been proposed that at least 2 ruminant subgroups exist: one represented by
RSV isolated from cattle and goat and the other represented by ovine RSV (Alansari et
al., 1999). The two PCR assays described in our study constitute potential sensitive and
specific means for simultaneous detection of both bovine and ovine RSV and
differentiation between them. RT-PCR F followed by the appropriate restriction enzyme
cleavage may be superior to RT-PCR G to classify ruminant RSV into two subgroups
because it resulted in the expected pattern for all the viruses tested. However, as indicated
earlier RT-PCR G followed by EcoO109I treatment did not give the expected cleavage
pattern with Bighorn RSV strain WSU 87-6750. Moreover, F gene is highly conserved
(>95%) among different bovine RSV strains (Pastey and Samal, 1993), whereas the G
gene is less conserved. According to one study, the nucleotide sequence identity among
G gene of different bovine RSV strains was 88-100% (Elvander et al., 1998). RT-PCR F
has the potential to determine the relative contribution of ovine RSV and bovine RSV to
the pathogenesis of bovine respiratory tract disease. This information would be relevant
to the complete understanding of RSV epidemiology and immunoprophylaxis. Further
studies are required to determine sensitivity and specificity of the two assays to detect
bovine and ovine RSVs in clinical samples from infected animals.
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Summary
Two antigenic subgroups A and B were defined for human respiratory syncytial
virus (HRSV) isolates on the basis of their reaction patterns with monoclonal antibodies
(Mufson et al., 1985; Anderson et al., 1985; Gimenez et al., 1986, Hendry et al., 1986).
Antigenic diversity of HRSV is associated with an extensive degree of amino acid
sequence divergence (53%) of the G protein between the two subgroups (Johnson et al.,
1987).
The attachment glycoprotein G of bovine respiratory syncytial virus (BRSV)
differed substantially from that of HRSV, whereas the bovine RSV F, N, M, and P
proteins cross-reacted antigenically with those of HRSV (Lerch et al., 1989). Early work
suggested that heterogeneity among 19 BRSV isolates exists based on reactivity with
monoclonal antibodies specific for G protein and two antigenic subgroups were identified
(Furze et al., 1994). However, sequence data revealed a high degree of amino acid
identity (85%) between the strains of the putative BRSV subgroups (Furze et al., 1997;
Prozzi et al., 1997). These findings were in sharp contrast to the HRSV antigenic
subgroups, where there is only 53% identity between A and B subgroups (Johnson et al.,
1987). It has been suggested that BRSV isolates form a continuum of slightly different
strains within a single subgroup rather than distinct subgroups (Prozzi et al., 1997, Stine
et al., 1997).
However, an RSV isolated from sheep was clearly distinguished from BRSV but
was more closely related to BRSV than to HRSV (Alansari and Potgieter, 1993;
Mallipeddi and Samal, 1993; Alansari and Potgieter, 1994a; Alansari and Potgieter,
1994b; Pastey and Samal, 1995; Alansari et al., 1999). It has been proposed that ruminant
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RSVs be divided into 2 subgroups, one representing bovine RSV, and the other
representing ovine RSV, based on analysis by RNAse protection of the G glycoprotein
transcripts and sequence comparison of ovine and bovine RSV-G protein genes (Alansari
and Potgieter, 1993; Alansari et al. 1999). Furthermore, variation in the reactivity of
bovine and ovine RSV with some monoclonal antibodies to the F protein of bovine RSV
(Pastey and Samal, 1997) supported this classification.
Some previous studies indicated possibility of interspecies transmission of bovine
and ovine RSVs. Experimental infection of lambs with BRSV produced mild clinical
signs and some pulmonary lesions (Lehmkuhl and Cutlip, 1979; Sharma and
Woldehiwet, 1991). Adair and McFerran, 1987 suggested that two related but
antigenically distinguishable RSV types may infect sheep, one of them may have been
BRSV. Inoculation of ORSV into calves and deer fawns resulted in mild to moderate
clinical respiratory disease only in calves. Lung lesions were detected in calves and fawns
and ORSV was reisolated from the lower respiratory tract of inoculated calves and fawns
(Bryson et al., 1988). Subgroup-specific, peptide-based ELISA derived from the unique
central hydrophobic region of the ovine and bovine G-glycoprotein, respectively were
used to determine the prevalence of antibodies against ovine and bovine subgroup strains
of RSV in cattle. The prevalence was 56-60% for the bovine strains and 15.9% for the
ovine strain (Grubbs et al., 2001 a; Grubbs et al., 2001 b).
Although these studies suggested that ovine RSV participates in the pathogenesis
of bovine respiratory tract disease, Confirmation of this hypothesis has not been possible
because a laboratory test differentiating between bovine and ovine RSV isolates did not
exist. The purpose of the present study was to develop reverse transcription-poymerase
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chain reaction (RT-PCR) assays for simultaneous detection of bovine and ovine RSVs
and differentiation between them. RSV isolation is inefficient because of its lability
(Smith et al., 1974). PCR assays for RSV may be more sensitive than
immunofluorescence (IF) (Vilcek et al., 1994; Valarcher et al., 1999) and ELISA (Larsen
et al., 1999; Valarcher et al., 1999) and as specific as IF and ELISA (Valarcher et al.,
1999) for the detection of BRSV infections. PCR assays have been recommended for
diagnosis of bovine RSV infections in cattle (Oberst et al., 1993; Vilcek et al., 1994;
Valarcher et al., 1999; Larsen et al., 1999). RSV PCR assays depend upon detection of
viral RNA or mRNA transcripts that are present in active infections, whereas serological
tests depend upon detection of antibodies, which develop during the convalescent phase
of infection. Therefore, an advantage of PCR tests over serological tests is that earlier
detection of infection is possible. Also, conventional serological diagnosis is dependent
upon paired serum samples taken during the acute and convalescent phases of the disease
and are not capable of discriminating between the ruminant RSV subgroups.
In this study, two structural protein genes were chosen as targets for the two PCR
assays; the fusion protein (F) for one assay and the attachment glycoprotein (G) gene for
the other assay. The F protein is more conserved ,whereas the G protein gene is the most
divergent viral protein among RSV strains (Lerch et al., 1990; Himes and Gershwin,
1992; Alansari and Potgieter, 1993). The nucleotide sequences of G protein genes of
BRSV and ORSV have been determined. But, the nucleotide sequence of F protein gene
is known only for BRSV. Therefore, the nucleotide sequence of ovine RSV F gene had to
be determined. For this purpose, two primers (F25 and F19) were derived from the 5’ end
of ovine RSV M2 gene and G-F intergenic region respectively (Alansari and Potgieter,
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1994; Mallipeddi and Samal, 1993). Sequencing was done in both directions, 5’ to 3’by
using the F19 primer, and 3’ to 5’ by using the F25 primer. The initial sequencing data
were used to design additional primers for sequencing the flanking regions. This strategy
was repeated to obtain the sequence of the whole product by assembly of overlapping
regions.
The ovine RSV F gene has 85%, 73% and 72% nucleotide identity with those of
bovine RSV, human RSV subgroup A and human RSV B subgroup respectively. The
predicted amino acid identity between the F protein of ovine RSV and those of bovine
RSV, human RSV subgroup A and human RSV subgroup B is 94%, 83% and 84%
respectively.
Based on this information, a PCR test targeting a specific fragment (426 bp) in the
F gene of both bovine RSV and ovine RSV has been developed (RT-PCR F). Also,
another assay amplifying 542 bp of both bovine and ovine RSV G genes has been
developed (RT-PCR G). The primers used in both assays were derived from conserved
sequences in bovine and ovine RSVs, bur that are not conserved in human RSV. This
allowed amplification of both bovine and ovine RSV, but not human RSV. Also, the
primers used did not have any homology with the sequences derived from other viruses
causing bovine respiratory tract disease; bovine parainfluenza, bovine virus diarrhea,
bovine coronavirus, bovine herpesvirus and bovine adenovirus. Sequencing of the PCR
products derived from ORSV and BRSV confirmed the validity of the two assays.
In RT-PCR-F assay, the PCR products obtained from bovine and ovine RSVs
could be distinguished by EcoRI treatment that resulted in two bands (285 and 141 bp)
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with ORSV and one band (426 bp) with BRSV or BstYI treatment that resulted in one
band (426 bp) with ORSV and 2 bands (361 and 65 bp) with.BRSV.
In RT-PCR G assay, PCR products obtained from bovine and ovine RSVs could
be distinguished by EcoO109I treatment that resulted in two bands (275 and 267 bp) with
ORSV and one band (542 bp) with BRSV or RsaI treatment that resulted in one band
(542 bp) with ORSV and two bands (391 and 151 bp) with BRSV.
The two assays were evaluated with eight different bovine RSV isolates (391-2,
375, FS1-1, NMK7, MN, CA, NY191285 and 1156R), ovine RSV isolate WSU 83-1578,
Bighorn sheep RSV isolate 87-6750, caprine RSV isolate, two human RSV isolates (A2
and B8/60) and several other viruses associated with bovine respiratory tract disease
(bovine parainfluenzavirus, bovine virus diarrhea virus, bovine coronavirus, bovine
herpesvirus and bovine adenovirus). All bovine RSV isolates tested were successfully
amplified by the two assays and resulted in an identical cleavage pattern. All of these
bovine isolates could be differentiated from ovine RSV by RT-PCR F and RT-PCR G
followed by the appropriate restriction enzyme treatment. The results with caprine RSV
were similar to those obtained with the bovine RSV isolates in both PCR assays.The
bovine/caprine isolates were clearly differentiated from the ovine RSV isolate. These
results confirm previous studies suggesting that caprine RSV is closely related to bovine
RSV isolates (Alansari et al., 1999). Amplification products were produced with the
Bighorn sheep RSV isolate WSU 87-6750 in the two assays. The RT-PCR F product
yielded the same cleavage pattern as the ovine RSV isolate WSU 83-1578 with EcoRI,
but the RT-PCR G product from the Bighorn isolate was not cleaved with EcoO109I or
RsaI. Sequence data of the target region indicated that this was due to a point mutation in
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the cleavage site. Nucleotide sequencing of amplified fragments of F and G genes of
Bighorn sheep isolate WSU 87-6750 indicated very high level of identity with ovine RSV
isolate WSU 83-1578 suggesting that the Bighorn RSV may be considered a member of
the ovine RSV subgroup.
Both assays gave a constant pattern with the eight bovine RSV isolates and the
caprine isolate that were clearly distinguished from the ovine RSV. Moreover, No PCR
products resulted in either assay with human RSV subgroup A (strain A2), human RSV
subgroup B (strain B8/60), bovine herpesvirus 1, bovine parainfluenza virus 3, bovine
virus diarrhea virus, bovine coronavirus or bovine adenovirus 3. This information reveal
that the two assays constitute a potential specific means for simultaneous detection and
differentiation of BRSV and ORSV.
PCR F and PCR G products with ovine and bovine RSV isolates were detected by
using as little as 0.06 ug and 0.03 ug respectively of total RNA indicating that the two
assays may be sensitive to detect very low amount of viral RNA.
RT-PCR F followed by the appropriate restriction enzyme cleavage may be
superior to RT-PCR G to classify ruminant RSV into two subgroups because it resulted in
the expected pattern for all the viruses tested. However, as indicated earlier, RT-PCR G
followed by EcoO109I treatment did not give the expected cleavage pattern with Bighorn
RSV strain WSU 87-6750. Moreover, F gene is highly conserved (>95%) among
different bovine RSV strains (Pastey and Samal, 1993), whereas the G gene is less
conserved. According to one study, the nucleotide sequence identity among G gene of
different bovine RSV strains was 88-100% (Elvander et al., 1998). RT-PCR F has the
potential to determine the relative contribution of ovine RSV and bovine RSV to the
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pathogenesis of bovine respiratory tract disease. This information would be relevant to
the complete understanding of RSV epidemiology and immunoprophylaxis. Further
studies are required to determine sensitivity and specificity of the two assays to detect
bovine and ovine RSVs in clinical samples from infected animals.
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